CytoReason’s machine-learning platform will help the pharma giant find the fastest route to new drug targets for autoimmune diseases.
Read more here.
CytoReason’s machine-learning platform will help the pharma giant find the fastest route to new drug targets for autoimmune diseases.
Read more here.
![[JUMP Bikes in Business Insider] Uber’s bike and scooter company appears to be expanding around the world ahead of its IPO](https://blog.mktg.ocdvlp.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
